We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
- Authors
Thompson, John A; Curti, Brendan D; Redman, Bruce G; Bhatia, Shailender; Weber, Jeffrey S; Agarwala, Sanjiv S; Sievers, Eric L; Hughes, Steven D; DeVries, Todd A; Hausman, Diana F
- Abstract
A phase I study of patients with metastatic malignant melanoma (MM) and renal cell carcinoma (RCC) evaluated the safety and maximum tolerated dose (MTD), pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of recombinant human interleukin-21 (rIL-21).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 12, p2034
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.14.5193